Hear more from our interview with Dr. Childs, where he talks about his inventive career in medicine and the best and worst parts of his day.
Recent Articles
BOSTON: Selinexor Improves Progression-Free Survival in Relapsed/Refractory Myeloma
The combination of once-weekly selinexor with bortezomib and dexamethasone (SVd) demonstrated a 30% reduction in the risk of disease progression or death, compared with...
CRISPR Gene Editing May Offer Curative Potential for Sickle Cell Disease
CRISPR-based gene editing techniques may offer curative potential for sickle cell disease (SCD) when used to target Krüppel-like factor 1 (KLF1) mutations, according to...
Editor’s Corner: A Period Piece
It happens every week in my clinic. I ask a patient one simple question and the floodgates open. I hear confessions of days upon...
Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms
Results from a CRISPR/Cas9 screening study suggest that loss of STK11 promotes progression to leukemia in patients with myeloproliferative neoplasms (MPNs), according to findings...
Current Issue
Mid-January 2021 Annual Meeting Edition
This issue features highlights from the 2020 ASH Annual Meeting, a look at doctor-patient gifting customs around the world, and more.